Similar articles

• Treatment of acute leukemia with amsacrine and high-dose cytarabine.

  Arlin ZA, Gaddipati J, Ahmed T, Mittelman A, Friedland M, Rieber E. Arlin ZA, et al. Cancer Treat Rep. 1985 Sep;69(9):1001-2. Cancer Treat Rep. 1985. PMID: 3839713
• Amsacrine with high-dose cytarabine in acute leukemia.

  Zittoun R, Bury J, Stryckmans P, Lowenberg B, Peetermans M, Rozendaal KY, Haanen C, Kerkhofs M, Jehn U, Willemze R. Zittoun R, et al. Cancer Treat Rep. 1985 Dec;69(12):1447-8. Cancer Treat Rep. 1985. PMID: 3841026 No abstract available.
• [Treatment of acute myeloid leukemia with amsacrine and high-dose cytosine arabinoside: a phase II trial].

  Marit G, David B, Reiffers J, Broustet A. Marit G, et al. Bull Cancer. 1985;72(1):37-41. Bull Cancer. 1985. PMID: 3857082 French.
• Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia.

  Arlin ZA. Arlin ZA. Cancer Treat Rep. 1983 Nov;67(11):967-70. Cancer Treat Rep. 1983. PMID: 6357436 Review. No abstract available.
• Cytosine arabinoside in experimental combination therapy.

  Edelstein M, Valeriote F. Edelstein M, et al. Semin Oncol. 1985 Jun;12(2 Suppl 3):75-83. Semin Oncol. 1985. PMID: 3892705 Review. No abstract available.